Manufacturer of Controlled Substances; Notice of Registration, 31314-31315 [E9-15446]

Download as PDF 31314 Federal Register / Vol. 74, No. 124 / Tuesday, June 30, 2009 / Notices CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: June 23, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–15443 Filed 6–29–09; 8:45 am] Springfield, Virginia 22152; and must be filed no later than August 31, 2009. Dated: June 22, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–15442 Filed 6–29–09; 8:45 am] BILLING CODE 4410–09–P Dated: June 23, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–15447 Filed 6–29–09; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE BILLING CODE 4410–09–P Drug Enforcement Administration DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on May 8, 2009, Chattem Chemicals Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule sroberts on PROD1PC70 with NOTICES6 4–Methoxyamphetamine (7411) ... Dihydromorphine (9145) ............... Amphetamine (1100) .................... Methamphetamine (1105) ............. Lisdexamfetamine (1205) ............. Methylphenidate (1724) ................ Pentobarbital (2270) ..................... Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................. Hydrocodone (9193) ..................... Meperidine (9230) ......................... Morphine (9300) ........................... Oripavine (9330) ........................... Thebaine (9333) ........................... Oxymorphone (9652) .................... Noroxymorphone (9668) ............... Alfentanil (9737) ............................ Remifentanil (9739) ...................... Sufentanil (9740) .......................... Fentanyl (9801) ............................. I I II II II II II II II II II II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, VerDate Nov<24>2008 19:55 Jun 29, 2009 Jkt 217001 By Notice dated September 22, 2008, and published in the Federal Register on September 29, 2008, (73 FR 56612), Johnson Matthey Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066–1742, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Gamma Hydroxybutyric Acid (2010), a basic class of controlled substance listed in schedule I. The company plans to produce sodium oxybate for sale to customers. One objection was received; however, the objector is not registered with DEA as a bulk manufacturer of Gamma Hydroxybutyric Acid (GHB). DEA has determined that the objection received is without merit and does not warrant denial of the application. DEA has also determined that the Food and Drug Administration does not preclude the sale of GHB to other manufacturers for the development of generic GHB products. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Johnson Matthey Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 Manufacturer of Controlled Substances; Notice of Registration By Notice dated June 19, 2008, and published in the Federal Register on June 27, 2008, (73 FR 36573), Norac Inc., 405 S. Motor Avenue, P.O. Box 577, Azusa, California 91702–3232, made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of Gamma Hydroxybutyric Acid (2010), a basic class of controlled substance listed in schedule I. The company plans to manufacture the listed controlled substance in bulk for sale to its customers. One objection was received; however, the objector is not registered with DEA as a bulk manufacturer of Gamma Hydroxybutyric Acid (GHB). DEA has determined that the objection received is without merit and does not warrant denial of the application. DEA has also determined that the Food & Drug Administration does not preclude the sale of GHB to other manufacturers for the development of generic GHB products. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Norac Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Norac Inc. to ensure that the company’s registration is consistent with the public interest. The investigation included the inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823 and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. E:\FR\FM\30JNN1.SGM 30JNN1 Federal Register / Vol. 74, No. 124 / Tuesday, June 30, 2009 / Notices Dated: June 23, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–15446 Filed 6–29–09; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Office of the Secretary Submission for OMB Review: Comment Request sroberts on PROD1PC70 with NOTICES6 June 25, 2009. The Department of Labor (DOL) hereby announces the submission of the following public information collection requests (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (Pub. L. 104–13, 44 U.S.C. chapter 35). A copy of each ICR, with applicable supporting documentation; including among other things a description of the likely respondents, proposed frequency of response, and estimated total burden may be obtained from the RegInfo.gov Web site at https://www.reginfo.gov/ public/do/PRAMain or by contacting Darrin King on 202–693–4129 (this is not a toll-free number)/e-mail: DOL_PRA_PUBLIC@dol.gov. Interested parties are encouraged to send comments to the Office of Information and Regulatory Affairs, Attn: OMB Desk Officer for the Department of Labor—Bureau of Labor Statistics (BLS), Office of Management and Budget, Room 10235, Washington, DC 20503, Telephone: 202–395–7316/ Fax: 202–395–5806 (these are not tollfree numbers), e-mail: OIRA_submission@omb.eop.gov within 30 days from the date of this publication in the Federal Register. In order to ensure the appropriate consideration, comments should reference the OMB Control Number (see below). The OMB is particularly interested in comments which: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and VerDate Nov<24>2008 19:55 Jun 29, 2009 Jkt 217001 • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Agency: Bureau of Labor Statistics. Type of Review: Extension without change of a currently approved collection. Title of Collection: General Inquiries to State Agency Contacts. OMB Control Number: 1220–0168. Affected Public: State, Local, and Tribal Governments. Total Estimated Number of Respondents: 54. Total Estimated Annual Burden Hours: 15,927. Total Estimated Annual Costs Burden: $0. Description: BLS awards funds to State Agencies in order to assist them in operating Labor Market Information and/or Occupational Safety and Health Statistics Federal/State cooperative statistical programs. To ensure a timely flow of data and to be able to evaluate and improve the programs it is necessary to conduct ongoing communications between BLS and the State partners dealing with, for example, deliverables, program enhancements, and administrative issues. For additional information, see related notice published at Vol. 74 FR 12386 on March 24, 2009. Agency: Bureau of Labor Statistics. Type of Review: Revision of a currently approved collection. Title of Collection: American Time Use Survey (ATUS). OMB Control Number: 1220–0175. Affected Public: Individuals or households. Total Estimated Number of Respondents: 13,240. Total Estimated Annual Burden Hours: 4,358. Total Estimated Annual Costs Burden: $0. Description: The ATUS is the Nation’s first federally administered, continuous survey on time use in the United States. It measures, for example, time spent with children, working, sleeping, or doing leisure activities. In the United States, several existing Federal surveys collect income and wage data for individuals and families, and analysts often use such measures of material prosperity as proxies for quality of life. Time-use data substantially augment these quality-of-life measures. The data also can be used in conjunction with PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 31315 wage data to evaluate the contribution of non-market work to national economies. This enables comparisons of production between nations that have different mixes of market and nonmarket activities. The ATUS develops nationally representative estimates of how people spend their time. Respondents also report who was with them during activities, where they were, how long each activity lasted, and if they were paid. All of this information has numerous practical applications for sociologists, economists, educators, government policymakers, businesspersons, health researchers, and others. The ATUS data are collected on an ongoing, monthly basis, allowing analysts to identify changes in how people spend their time. The survey sample is drawn from households completing their final month of interviews for the Current Population Survey (CPS). Households are selected to ensure a representative demographic sample, and one individual from each household is selected to take part in one Computer Assisted Telephone Interview. The interview asks respondents to report all of their activities for one pre-assigned 24-hour day, the day prior to the interview. A short series of summary questions and CPS updates follows the core time diary collection. For additional information, see related notice published at Vol. 74 FR 14160 on March 30, 2009. Darrin A. King, Departmental Clearance Officer. [FR Doc. E9–15433 Filed 6–29–09; 8:45 am] BILLING CODE 4510–24–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice 09–061] NASA Advisory Council; Meeting AGENCY: National Aeronautics and Space Administration. ACTION: Notice of meeting. SUMMARY: In accordance with the Federal Advisory Committee Act, Public Law 92–463, as amended, the National Aeronautics and Space Administration announces a meeting of the NASA Advisory Council’s Aeronautics, Audit and Finance, Exploration, Human Capital, Science, and Space Operations Committees. The agendas for the committees include updates from the prior NAC meeting held at NASA Headquarters in April 2009 as well as discussion of potential E:\FR\FM\30JNN1.SGM 30JNN1

Agencies

[Federal Register Volume 74, Number 124 (Tuesday, June 30, 2009)]
[Notices]
[Pages 31314-31315]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-15446]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 19, 2008, and published in the Federal 
Register on June 27, 2008, (73 FR 36573), Norac Inc., 405 S. Motor 
Avenue, P.O. Box 577, Azusa, California 91702-3232, made application by 
letter to the Drug Enforcement Administration (DEA) for registration as 
a bulk manufacturer of Gamma Hydroxybutyric Acid (2010), a basic class 
of controlled substance listed in schedule I.
    The company plans to manufacture the listed controlled substance in 
bulk for sale to its customers.
    One objection was received; however, the objector is not registered 
with DEA as a bulk manufacturer of Gamma Hydroxybutyric Acid (GHB). DEA 
has determined that the objection received is without merit and does 
not warrant denial of the application. DEA has also determined that the 
Food & Drug Administration does not preclude the sale of GHB to other 
manufacturers for the development of generic GHB products.
    DEA has considered the factors in 21 U.S.C. 823(a) and determined 
that the registration of Norac Inc. to manufacture the listed basic 
class of controlled substance is consistent with the public interest at 
this time. DEA has investigated Norac Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
included the inspection and testing of the company's physical security 
systems, verification of the company's compliance with State and local 
laws, and a review of the company's background and history.
    Therefore, pursuant to 21 U.S.C. 823 and in accordance with 21 CFR 
1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic class of controlled substance listed.


[[Page 31315]]


    Dated: June 23, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-15446 Filed 6-29-09; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.